MEDICO REMEDIES
|
|
BOM : 540937     NSE : MEDICO     | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive] Debt : Average |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Upward Pledged Shares : NA |
Nov 13,2024 |
Price(EOD): ₹ 56.61
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 469.86 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
MEDICO REMEDIES | -2.3% | 12.3% | -27.3% |
SUN PHARMACEUTICAL INDUSTRIES | -0.7% | -6.2% | 52.6% |
CIPLA | -4.3% | -4.2% | 23% |
DR REDDYS LABORATORIES | -3.2% | -5.9% | 16.4% |
ZYDUS LIFESCIENCES | -0.9% | -8.9% | 53.3% |
DIVIS LABORATORIES | -3.1% | -5.5% | 66.2% |
MANKIND PHARMA | -7.2% | -7.8% | 43.7% |
TORRENT PHARMACEUTICALS | -1.2% | -10.7% | 53.1% |
LUPIN | -3.4% | -9.4% | 76.9% |
FUNDAMENTAL ANALYSIS OF MEDICO REMEDIES
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF MEDICO REMEDIES
 Ratio | Standalone | |
---|---|---|
P/E P/B P/S |
54.95
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 7.68 Cr
[Latest Qtr - Sep2024 - Standalone Results ] 8.97
P/B Calculated based on Book Value of Rs 52.37 Cr
[Latest Year - Mar2024 - Standalone Results ] 3.26
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Sep2024 - Standalone Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
456% 708% 597% |
SHARE PRICE MOMENTUM OF MEDICO REMEDIES
MEDICO REMEDIES vs SENSEX
DEBT OF MEDICO REMEDIES
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
0.13 0.18 0.29 0.2 |
- - - - |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF MEDICO REMEDIES
Pledged Promoter Shares |
NA | |
---|---|---|
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF MEDICO REMEDIES
Standalone | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
27.76% -14.09% -1.93% -1.52% |
-7.1% -21.55% -32.16% -35.9% |
QtrlyTrend |
-6 | |
Latest Qtr: Sep2024 | ||
Quarterly Result Analysis → |
MEDICO REMEDIES related INDICES
You may also like the below Video Courses
FAQ about MEDICO REMEDIES
Is MEDICO REMEDIES good for long term investment?
As on Nov 13,2024, the Fundamentals of MEDICO REMEDIES look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of MEDICO REMEDIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is MEDICO REMEDIES UnderValued or OverValued?
As on Nov 13,2024, MEDICO REMEDIES is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of MEDICO REMEDIES ?
As on Nov 13,2024, the Intrinsic Value of MEDICO REMEDIES is Rs. 8.12 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 10.18
Fair Value [Median EV / Sales Model] : Rs. 7.01
Fair Value [Median Price / Sales Model] : Rs. 8.12
Estimated Median Fair Value of MEDICO REMEDIES : Rs. 8.12
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.